Back

Current treatment for elevated lipoprotein(a).

27 August 2021 (08:11 - 08:22)
Organised by:
Congress Presentation Part of: Lipoprotein(a): an emerging lipid risk factor Risk Factors and Prevention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Anne Carol Goldberg

The Washington University, Saint Louis (United States of America)

3 More presentations in this session

Presentation thumbnail
Lipoprotein(a) and cardiovascular risk.
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Future treatments for lipoprotein(a).
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Lipoprotein(a): an emerging lipid risk factor – discussion.

Access the full session

Session thumbnail
Lipoprotein(a): an emerging lipid risk factor
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:11 CET
You may be interested in
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore
4 April 2025
thumbnail
Congress Presentation
Valvular proteomic and micro-CT analysis in severe aortic stenosis patients with normal and elevated lipoprotein(a) levels
1 September 2025
thumbnail
Congress Presentation
Aspirin use for prevention of cardiovascular events in patients with high lipoprotein(a): a population-based study
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources